Literature DB >> 27751366

Genetic Polymorphisms in SOD (rs2070424, rs7880) and CAT (rs7943316, rs1001179) Enzymes Are Associated with Increased Body Fat Percentage and Visceral Fat in an Obese Population from Central Mexico.

César Hernández-Guerrero1, Paulina Hernández-Chávez2, Inés Romo-Palafox2, Grecia Blanco-Melo2, Alicia Parra-Carriedo2, Ana Pérez-Lizaur3.   

Abstract

BACKGROUND AND AIMS: Oxidative disturbance is an important factor involved in the etiology of comorbidities associated with obesity. Genetic polymorphisms such as SOD1 -251A>G, SOD2 47 C>T, CAT -21A>T and CAT -262 C>T have been described to alter the activity of antioxidant enzymes. The aim of the present work was to analyze the association of the mentioned SNPs with obesity and their relationship with anthropometric and clinical variables in this group.
METHODS: The study included 416 Mexican women (208 normal weight, NW and 208 subjects with obesity, OB). Dietary intake, anthropometric, biochemical and clinical features were evaluated and then analyzed in function of the genotypes.
RESULTS: The mutated carriers (GA+GG) of SOD -251 were significantly higher in the OB group (0.24) compared to the NW group (0.08). The other SNPs showed no differences compared with control group. When comparing carrier mutated subjects with obesity vs. wild-type obese participants with the SNPs SOD1 -251, SOD2 47 and CAT -262, the carriers showed a significantly (p <0.05) higher value in body fat percentage. Also, carriers of SOD2 47 and CAT-262 showed significantly higher values (p = 0.002) and (p = 0.01), respectively, when visceral fat was compared between groups. Systolic blood pressure was significantly higher (p = 0.02) in carriers of mutated CAT-21.
CONCLUSION: SOD1 -251A>G is associated with obesity independent of the presence of diabetes or dyslipidemia. Mutated obese carries of SOD1 -251, SOD2 47 and CAT -262 are associated with a higher distribution of fat in comparison with obese wild-type carriers.
Copyright © 2016 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catalase; Genetic polymorphisms; Obesity; Oxidative disturbance; Superoxide dismutase

Mesh:

Substances:

Year:  2016        PMID: 27751366     DOI: 10.1016/j.arcmed.2016.08.007

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  10 in total

Review 1.  Determinants of body fat distribution in humans may provide insight about obesity-related health risks.

Authors:  Aaron P Frank; Roberta de Souza Santos; Biff F Palmer; Deborah J Clegg
Journal:  J Lipid Res       Date:  2018-08-10       Impact factor: 5.922

2.  The Activity of Superoxide Dismutase, Its Relationship with the Concentration of Zinc and Copper and the Prevalence of rs2070424 Superoxide Dismutase Gene in Women with Polycystic Ovary Syndrome-Preliminary Study.

Authors:  Anna Bizoń; Agata Tchórz; Paweł Madej; Marcin Leśniewski; Mariusz Wójtowicz; Agnieszka Piwowar; Grzegorz Franik
Journal:  J Clin Med       Date:  2022-05-01       Impact factor: 4.964

Review 3.  Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects.

Authors:  S Porro; V A Genchi; A Cignarelli; A Natalicchio; L Laviola; F Giorgino; S Perrini
Journal:  J Endocrinol Invest       Date:  2020-11-03       Impact factor: 4.256

4.  Comparison of CAT-21A/T Gene Polymorphism in Women with Preeclampsia and Control Group.

Authors:  Fakhrolmolouk Yassaee; Saeedeh Salimi; Samaneh Etemadi; Minoo Yaghmaei
Journal:  Adv Biomed Res       Date:  2018-10-24

5.  Interactions between plasma copper concentrations and SOD1 gene polymorphism for impaired glucose regulation and type 2 diabetes.

Authors:  Jiawei Yin; Xiaoqian Wang; Shuzhen Li; Yalun Zhu; Sijing Chen; Peiyun Li; Cheng Luo; Yue Huang; Xiaoqin Li; Xueting Hu; Wei Yang; Wei Bao; Zhilei Shan; Liegang Liu
Journal:  Redox Biol       Date:  2019-03-18       Impact factor: 11.799

6.  Antioxidants-Related Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Peroxidase (GPX), Glutathione-S-Transferase (GST), and Nitric Oxide Synthase (NOS) Gene Variants Analysis in an Obese Population: A Preliminary Case-Control Study.

Authors:  Amani M T Gusti; Safaa Y Qusti; Eida M Alshammari; Eman A Toraih; Manal S Fawzy
Journal:  Antioxidants (Basel)       Date:  2021-04-13

7.  Genetic polymorphisms of genes involved in oxidative stress and inflammatory management in oncopediatric patients with chemo-induced oral mucositis.

Authors:  Marina Castro Coêlho; José Maria Chagas Viana Filho; Beatriz Fernandes de Souza; Ana Maria Gondim Valença; Darlene Camati Persuhn; Naila Francis Paulo de Oliveira
Journal:  J Appl Oral Sci       Date:  2022-03-23       Impact factor: 2.698

8.  Association study between superoxide Dismutases gene polymorphisms and development of diabetic retinopathy and cataract in Iranian patients with type two diabetes mellitus.

Authors:  Leila Saremi; Somayye Taghvaei; Fatemeh Feizy; Mohammad Ebrahim Ghaffari; Sepideh Babaniamansour; Zohreh Saltanatpour
Journal:  J Diabetes Metab Disord       Date:  2021-04-04

9.  Genetic polymorphisms of antioxidant enzymes CAT and SOD affect the outcome of clinical, biochemical, and anthropometric variables in people with obesity under a dietary intervention.

Authors:  César Hernández-Guerrero; Alicia Parra-Carriedo; Diana Ruiz-de-Santiago; Oscar Galicia-Castillo; Mario Buenrostro-Jáuregui; Carmen Díaz-Gutiérrez
Journal:  Genes Nutr       Date:  2018-01-08       Impact factor: 5.523

10.  Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people.

Authors:  Ivo Emilio da Cruz Jung; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Alexis Trott; Lucien J Houenou; Bárbara Osmarin Turra; Thiago Duarte; Raquel de Souza Praia; Ednea Aguiar Maia-Ribeiro; Jaqueline da Costa Escobar Piccoli; Claudia Giugliano Bica; Marta Maria Medeiros Frescura Duarte
Journal:  Mol Genet Genomic Med       Date:  2019-12-31       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.